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Abstract
Introduction:  A  systemic  inﬂamatory  response  is  common  after  EVAR.  Its  clinical  impact  is
unknown,  and  although  is  it  usually  well  tolerated,  there  is  concern  it  might  be  associated  with
increased morbidity  and  mortality  in  high  risk  patients.  This  study  aims  to  evaluate  the  occur-
rence of  the  post-implantation  syndrome  (PIS)  in  patients  undergoing  EVAR,  its  characteristics
and clinical  signiﬁcance.
Methods:  This  study  is  a  retrospective  observational  analysis  of  patients  undergoing  elective
EVAR between  November  2012  and  November  2014.  PIS  was  deﬁned  by  fever  (>38 ◦C)  and  leuko-
cytosis (>12,000  L−1),  excluding  infectious  complications.  We  evaluated  the  epidemiological
characteristics  of  the  patient,  aneurysm  and  procedure  characteristics  and  their  relationship
with development  of  PIS.
Results:  Fifty-two  patients  were  included,  and  21.2%  were  diagnosed  with  PIS.  The  ePTFE  grafts
were not  associated  with  the  occurrence  of  the  syndrome,  in  contrast  with  polyester  stent  grafts
(0% vs.  28.2%,  p  =  0.031).  The  age  and  gender  of  patients,  the  diameter  of  the  aneurysm,  dura-
tion and  radiation  dose  and  the  conﬁguration  of  the  stent  graft  (aorto-bi-iliac,  aorto-uni-iliac
or fenestrated)  were  not  associated  with  PIS.  There  was  no  statistically  signiﬁcant  difference
in the  occurrence  of  major  cardiovascular  events  during  hospitalization  in  both  groups.
Conclusion:  The  inﬂammatory  syndrome  after  EVAR  occurs  in  a  signiﬁcant  percentage  of
patients (21%).  Stent  grafts  constructed  by  polyester  are  a  signiﬁcant  risk  factor.  Despite  the
exuberant  inﬂammatory  response,  it  was  not  associated  with  increased  occurrence  of  cardio-
vascular events,  and  it  is  usually  benign,  well  tolerated  and  self-limiting.
© 2015  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Published  by  Elsevier  España,
ss  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.
).S.L.U. This  is  an  open  acce
org/licenses/by-nc-nd/4.0/∗ Corresponding author.
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Síndrome  inﬂamatório  pós-EVAR  --  análise  retrospectiva  de  52  doentes  tratados
Resumo
Introduc¸ão:  É  frequente  uma  resposta  inﬂamatória  sistémica  após  EVAR.  O  seu  impacto  clínico
é desconhecido,  e  apesar  de  habitualmente  ser  bem  tolerado  existe  o  receio  de  estar  asso-
ciado a  maior  morbi-mortalidade  em  doentes  de  alto  risco.  Este  estudo  tem  como  objectivo
a avaliac¸ão  da  ocorrência  do  síndrome  pós-implantac¸ão  (SPI)  nos  doentes  submetidos  a  EVAR,
suas características  e  relevância  clínica.
Material  e  métodos:  Estudo  observacional  retrospectico  de  doentes  submetidos  a  EVAR  electivo
entre Novembro  de  2012  e  Novembro  de  2014.  O  SPI  foi  deﬁnido  por  febre  (>38 ◦C)  e  leucocitose
(>12.000/L), excluídas  complicac¸ões  infecciosas.  O  outcome  primário  foi  o  diagnóstico  de  SPI.
Foram avaliadas  as  características  epidemiológicas  do  doente,  características  do  aneurisma  e
do procedimento  e  sua  relac¸ão  com  o  SPI.
Resultados:  Foram  incluídos  52  doentes,  dos  quais  21,2%  desenvolveram  SPI.  As  endopróteses
de ePTFE  não  foram  associadas  à  ocorrência  de  SPI,  comparativamente  às  de  poliéster  (0%  vs.
28,2%, p  =  0.031).  A  idade  e  o  sexo  dos  pacientes,  o  diâmetro  do  aneurisma,  o  tempo  e  a  dose  de
radiac¸ão e  a  conﬁgurac¸ão  da  endoprótese  (aorto-bi-ilíaca,  aorto-uni-ilíaca  ou  fenestrada)  não
foram associados  à  ocorrência  do  síndrome.  Não  se  observaram  diferenc¸as  estatisticamente  sig-
niﬁcativas na  ocorrência  de  eventos  cardiovasculares  major  durante  o  internamento  em  ambos
os grupos.
Conclusão:  O  SPI  ocorre  numa  percentagem  signiﬁcativa  de  doentes  (21%).  As  endopróteses
construídas  com  poliéster  são  um  factor  de  risco  signiﬁcativo.  Apesar  da  resposta  inﬂamatória
exuberante,  esta  não  se  associou  à  ocorrência  de  eventos  cardiovasculares,  sendo  habitual-
mente benigna,  bem  tolerada  e  auto-limitada.
© 2015  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Publicado  por  Elsevier  España,
S.L.U. Este  é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.
).
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Introduction
After  implantation  of  a  stent  graft  in  endovascular  repair  of
abdominal  aortic  aneurysm  (EVAR)  it  is  common  a  systemic
inﬂammatory  response,  which  sometimes  is  exuberant.  The
inﬂammatory  syndrome  after  EVAR,  or  post-implantation
syndrome  (PIS),  is  deﬁned  by  fever  and  leukocytosis  in
the  postoperative  period  when  infectious  complications  are
excluded.1,2 Despite  being  described  since  1999,2 the  etio-
logic  mechanisms,  its  signiﬁcance  and  its  consequences  are
yet  not  fully  understood.  The  incidence  differs  in  the  pub-
lished  studies,  in  part  due  to  different  diagnostic  criteria,
and  it  is  estimated  from  14%  to  60%.1--6 The  inﬂammatory
reaction  is  attributed  to  endothelial  dysfunction  in  contact
with  the  graft  material.7 Acute  thrombus  formation  in  the
aneurysmal  sac  may  also  contribute.7 The  clinical  impact  of
this  inﬂammatory  response  is  unknown,  and  although  it  is
usually  well  tolerated  and  self-limiting  and  there  is  concern
that  it  could  be  associated  with  worse  prognosis  and  higher
morbidity  and  mortality  in  high  cardiovascular  risk  patients.
The  necessity  of  treatment  and  the  most  appropriate  type
of  treatment  remains  controversial.
This  study  aims  to  evaluate  the  occurrence  of  post-
implantation  syndrome  in  our  patients  submitted  to  elective
endovascular  repair  of  abdominal  aortic  aneurysm,  its  char-
acteristics  and  its  clinical  signiﬁcance.
Materials and methodsThis  study  is  a  retrospective  observational  analysis  of
the  abdominal  aortic  aneurysms  treated  by  elective
p
o
iVAR  between  November  of  2012  and  November  of
014.  All  patients  undergoing  EVAR  consecutively  were
ncluded.  Infectious  aneurysms,  ruptured  aneurysms  and
alse  aneurysms  were  excluded  from  the  analysis.  We
roceed  to  systematically  review  the  electronic  clinical
ecords,  with  evaluation  of  the  epidemiological  characteris-
ics  of  patients  (age  and  gender),  auricular  temperature  and
nalytical  parameters  (erythrocytes,  leukocytes,  platelets,
 reactive  protein  (CRP)),  before  and  after  the  procedure.
he  temperature  evaluation  was  performed  on  the  patient
dmission  to  the  hospital,  and  after  that,  at  every  standard
ard  shift  (every  6  h).  Analytical  blood  evaluation  was  per-
ormed  at  patient’s  admission  to  the  hospital,  on  the  ﬁrst
ostoperative  day,  and  after  that,  at  variable  timing,  by
ecision  of  the  treating  physician.  Aneurysm  features  diam-
ter,  location),  characteristics  of  stent  graft  (conﬁguration
f  the  endoprosthesis  (aorto-uni-iliac,  aorto-bi-iliac,  fEVAR),
anufacturer,  model  and  construction  material)  and  the
rocedure  approach  used  (percutaneous  or  surgical  cutdown
emoral  access)  were  also  registered.  The  radiation  dose,
he  ﬂuoroscopy  time  of  the  intervention  and  the  length  of
tay  (total  hospital  stay  and  on  intermediate  care  unit)  were
nalyzed.  Major  complications  and  the  occurrence  of  car-
iovascular  events  (myocardial  ischemia  with  EKG  signs  or
ymptomatic  elevation  of  myocardial  ischemia  markers  or
cute  cerebrovascular  events)  in  the  postoperative  period
ere  also  recorded.
The  post-implantation  syndrome  was  deﬁned  by  theresence  of  leukocytosis  (>12,000  leukocytes/L) plus  the
ccurrence  of  fever  (>38 ◦C  --  auricular  temperature)  dur-
ng  the  postoperative  period  when  infectious  complications
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Table  1  Sample  characteristics.
Total  PIS  No  PIS  p
Age  (years) 77.6 81.2  76.6  0.066
AAA diameter  (mm)  60.8  65.1  59.6  0.395
Males 94.2%  (49)  18.4%  (9)  81.6%  (40)  0.078
Females 5.8%  (3)  66.7%  (2)  33.3%  (1)  0.078
Radiation dose  (mGym2)  4.63  4.72  4.59  0.306
Fluoroscopy time  (min)  24.6  22.97  25.1  0.118
Total hospital  stay  (days)  7.2  8.36  6.85  0.346
ICU (days)  1.85  2.18  1.76  0.064
Percutaneous  approach 9.6%  (5) 20%  (1) 80%  (4)  0.342
Cardiovascular  events 5.8%  (3) 5.3%  (1) 6.1%  (2) 1.000
e; ICU, intermediate care unit.
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Figure  1  Distribution  of  leukocyte  count.
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Figure  2  Distribution  of  neutrophil  count.
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ere  excluded  (no  clinical  evidence  of  infection,  negative
lood  cultures,  absence  of  local  complications  of  the  surgi-
al  wound).1 All  patients  included  were  treated  by  the  same
urgical  and  anesthesiology  team  in  an  operating  theater
oom,  in  an  University  Hospital  Center.  All  patients  fulﬁlled
he  criteria  of  suitability  for  endovascular  repair  deﬁned
n  the  literature.8 Prophylactic  antibiotic  (cefazolin,  2  g)
as  routinely  administered  to  all  patients  before  the  pro-
edure.  The  stent-grafts  used  were  Endurant  II  (Medtronic
nc®,  Santa  Rosa,  CA,  USA),  Zenith  Fenestrated  Endovascular
raft  (Cook  Inc.®,  Indianapolis,  IN,  USA)  and  Excluder  (WL
ore  &  Associates®,  Flagstaff,  AZ,  USA).  The  ﬁrst  two  were
onstructed  with  polyester,  and  the  latter  is  constructed
ith  ePTFE.  Atrium  Advanta  V12  covered  stents  (ePTFE  cov-
red)  were  used  in  the  fenestrated  procedures.
The  statistical  treatment  of  data  was  performed  with
PSS  Statistics  21.0® (IBM).  The  evaluation  of  the  statis-
ical  signiﬁcance  of  the  differences  found  was  performed
ith  Qui2 tests,  Student’s  t  test  and  Fisher  exact  test  when
ppropriate.  Statistical  signiﬁcance  was  considered  for  dif-
erences  of  0.05.
esults
his  study  included  52  patients  with  an  average  age  of
7.6  years  (standard  deviation  9.4,  minimum  58,  maximum
4)  and  94.2%  were  male  (Table  1).  Of  these  patients,
1.2%  developed  post-implantation  syndrome.  On  the  post-
perative  period,  44.2%  of  the  patients  had  leukocytosis.
he  development  of  leukocytosis  and  neutrophilia  had  a
apid  rise  and  peak  in  the  ﬁrst  24  h  after  implantation  of
he  stentgraft,  with  a  slow  and  steady  decline  thereafter
Graphs  1  and  2).  The  increase  in  CRP  was  slower,  with  peak
t  96  h  (Graph  3).  Fever  affected  more  than  half  of  patients
55.7%).  The  temperature  increased  rapidly,  peaking  within
4  h,  and  remained  high  over  the  next  few  days  (Graph  4).
The  mean  diameter  of  aneurysms  was  60.8  mm  (minimum
0  mm,  maximum  95  mm),  and  an  association  between  the
iameter  of  the  aneurysm  and  the  occurrence  of  PIS  was  not
bserved  (Table  1).Regarding  the  stent  graft  morphology,  73.1%  were  treated
ith  aorto-bi-iliac  stent-graft,  19.2%  with  aorto-uni-iliac
tent  and  7.7%  with  fEVAR.  Considering  the  manufacturer
f  the  endoprosthesis,  67.3%  were  treated  with  Endurant  II,
–50
Time (hours)
Figure  3  Distribution  of  CRP.
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Table  2  Relationship  between  stent-graft  characteristics  and  PIS.
Total  PIS  No  PIS  p
Polyester  75.0%  (39)  28.2%  (11)  71.8%  (28)  0.031
ePTFE 25.0%  (13)  0%  (0)  100%  (13)  0.031
Endurant II  67.3%  (35)  31.4%  (11)  68.6%  (24)  0.006
Excluder 25.0%  (13)  0.0%  (0)  100.0%  (13)  0.006
Zenith 7.7%  (4)  0.0%  (0)  100.0%  (4)  0.006
ABI 73.1%  (38)  18.4%  (7)  81.6%  (31)  0.143
AUI 19.2%  (10)  40%  (4)  60%  (6)  0.143
fEVAR 7.7%  (4)  0.0%  (0)  100.0%  (4)  0.143
ABI, aorto-bi-iliac; AUI, aorto-uni-iliac; fEVAR, fenestrated stent-graft;
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Figure  4  Distribution  of  temperature.
25.0%  with  Excluder  and  7.7%  with  Zenith  stent-graft.  The
ePTFE  grafts  were  not  associated  with  the  occurrence  of  the
syndrome,  on  contrary  to  the  polyester  endoprosthesis  (0%
vs.  28.2%,  p  =  0.031).  The  subgroups  treated  with  Zenith  and
Excluder  stents  had  no  occurrence  of  PIS,  p  =  0.006  (Table  2).
Regarding  the  procedure  approach,  the  majority  of  patients
(90.4%)  were  treated  with  surgical  cut  down  femoral  access
and  9.6%  of  patients  were  treated  with  percutaneous  access,
with  no  statistical  signiﬁcant  inﬂuence  on  the  occurrence  of
PIS  (Table  1).
The  age  and  gender  of  the  patients,  the  diameter  of  the
aneurysm,  ﬂuoroscopy  time  and  radiation  dose  (Table  1),
and  the  morphological  conﬁguration  of  the  stent  (aorto-bi-
iliac,  aorto-uni-iliac  or  fenestrated)  had  no  relationship  with
the  occurrence  of  PIS  (Table  1).  The  development  of  the
inﬂammatory  syndrome  was  associated  with  a  higher  total
hospital  stay  (8.63  vs.  6.85  days,  p  =  0346)  and  on  interme-
diate  care  unit  (2.18  vs.  1.76  days,  p  =  0.064),  although  with
no  statistically  signiﬁcant  difference  (Table  1).
With  regard  to  the  analytical  data,  patients  who  devel-
oped  PIS  had  higher  baseline  CRP,  compared  to  patients  who
did  not  develop  the  syndrome  (11.92  mg/dL  vs.  4.36  mg/dL,
p  =  0.005).  There  were  no  other  associations  between  PIS  and
the  base-line  analytical  data.
There  were  no  statistically  signiﬁcant  differences  in  the
occurrence  of  major  cardiovascular  events  during  hospital-
ization  in  both  groups  (5.3%  vs.  6.1%,  p  =  1.000)  (Table  1).Discussion
In  this  study  we  found  a  signiﬁcant  incidence  of  PIS  (21%)
in  patients  undergoing  EVAR.  This  incidence  rate  is  in
D
p
v
P PIS, post-implantation syndrome.
greement  with  the  published  literature,  which  varies
rom  14%  to  60%.1--6 This  variation  is  in  part  explained  by
ifferent  diagnostic  criteria.  Some  authors  use  as  criteria,
he  development  of  fever  and  CRP  elevation,  while  oth-
rs  authors  use  as  criteria,  the  occurrence  of  fever  and
eukocytosis,  with  different  cut-off  values  for  each  of  these
ariables.
The  stent-graft  construction  material  appears  to  be
he  major  risk  factor  for  the  development  of  PIS.9,10 In
his  study,  no  patient  treated  with  ePTFE  graft  fulﬁlled
ur  criteria  of  PIS.  Thus,  the  occurrence  of  fever  or
eukocytosis  in  patients  with  ePTFE  grafts  should  raise
he  suspicion  of  other  complications  and  trigger  off  the
dequate  investigation.  We  found  no  PIS  on  patients
reated  with  the  Zenith  stent-graft,  which  is  also  con-
tructed  with  polyester.  This  might  be  explained  by  the
ow  number  of  cases  treated  with  this  stent  in  our
eries.
The  occurrence  of  PIS  led  to  prolongation  of  the  time  of
otal  hospital  stay  and  in  intermediate  care  unit,  although
ithout  statistically  signiﬁcant  differences.  The  exuberant
nﬂammatory  response  and  clinical  concern  of  a  possible
nfection  may  be  responsible  for  prolongation  of  the  hos-
italization  and  maybe  the  unnecessary  prescription  of
ntibiotics  and  unnecessary  diagnostic  tests,  associated  with
ncreased  risks  and  health-care  costs.  Procalcitonin  is  a
iomarker  of  bacterial  infection  and  sepsis.  A prospective
ilot  study  demonstrated  the  effectiveness  of  procalci-
onin  assay  in  peripheral  blood  to  differentiate  the  PIS  and
nfection.11 Thus  the  determination  of  procalcitonin  can
elp  to  avoid  unnecessary  treatment  and  clinical  investiga-
ion.
We  found  no  association  between  the  development  of  PIS
nd  the  occurrence  of  major  cardiovascular  events.  Activa-
ion  of  inﬂammatory  signaling  pathways  with  the  consequent
elease  of  pro-inﬂammatory  cytokines,  leukocyte  activa-
ion  and  proliferation,  may  be  associated  with  increased
ostoperative  morbidity  and  mortality,  especially  in  high
isk  patients.12,13 A  prospective  study  that  evaluated  the
ccurrence  of  PIS  in  patients  undergoing  EVAR  showed  that
he  magnitude  of  inﬂammation  (measured  by  the  maximum
alue  of  high  sensitivity  CRP)  correlated  with  adverse  car-
iovascular  events  within  30  days  after  the  procedure.1
ue  to  the  retrospective  design  of  the  study,  it  was  not
ossible  to  investigate  the  presence  of  asymptomatic  ele-
ation  of  myocardial  ischemia  markers  and  its  relation  to
IS.
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The  necessity  of  treatment  is  controversial.  Some  authors
uggest  the  use  of  non-steroidal  anti-inﬂammatory  drugs
r  glucocorticoids  routinely  to  limit  the  inﬂammatory
esponse.4,14 A  prospective  series  that  assessed  the  effect
f  antibiotics  in  the  treatment  of  PIS  showed  no  bene-
t  of  prolonged  antibiotic  prophylaxis  beyond  the  usual
eriod.15 We  did  not  apply  any  speciﬁc  treatment  to  the
atients  diagnosed  with  PIS.  No  patient  was  treated  with
nti-inﬂammatory  drugs  during  the  hospitalization,  with
xception  for  acetylsalicylic  acid,  which  was  prescribed  to
very  patient.
onclusion
he  inﬂammatory  syndrome  after  EVAR  occurs  in  a  sig-
iﬁcant  percentage  of  patients,  21%  in  this  study.  The
onstruction  material  of  the  stent-graft  appears  to  be
he  key  factor  in  the  development  of  the  inﬂammatory
esponse.  Polyester  is  the  most  important  risk  factor  in  the
ccurrence  of  the  syndrome,  in  agreement  with  other  pub-
ished  series.1,3,6,9,10 There  was  no  PIS  diagnosed  in  patients
reated  with  ePTFE  stents,  and  therefore,  the  occurrence
f  fever  or  leukocytosis  on  these  patients  should  raise  the
uspicion  of  other  complications.  Although  this  inﬂamma-
ory  response  might  be  exuberant,  it  was  not  associated
ith  increased  cardiovascular  events  in  the  postoperative
eriod,  and  it  is  usually  benign,  well  tolerated  and  self-
imiting.
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